Tender Details

Country: Germany
Summary: Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Ranolazine
DET Ref No: 98677240
Deadline: 11 Nov 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 151461-2024
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
§130a Paragraph 8 SGB V enables health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory KK. The GWQ is a society for efficiency and quality at KK in accordance with Section 130a Paragraph 8 Sentence 5 SGB V for its employeestionary and customer cash registers. With regard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal procurement procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Until In the entry into force of new drug discount agreements, the GWQ would like to enter into drug discount agreements with all interested pharmaceutical companies as part of the open house procedure for preparations with, among other things. Complete active ingredient. The earliest contract start date is February 1st, 2023.
Ranolazine
The GWQ ServicePlus AG also intends to enter into non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V or the like. Active ingredient with contract start on February 1st, 2023. All interested companies can join this contract at any time during the contract term under the same conditions (approval model).The GWQ assumes that this procedure does not fall within the scope of antitrust procurement law due to the lack of a selection decision and therefore the non-discriminatory access of all pharmaceutical companies. The contract documents, the participating health insurance company...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Ranolazine - Germany Tender

The GWQ SERVICEPLUS AG, a Government sector organization in Germany, has announced a new tender for Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Ranolazine. This tender is published on GermanyTenders under DET Ref No: 98677240 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-11-11.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.